IP Library Granted Patent US 8,058,499
Granted Patent B2
US 8,058,499 · App. 10/496,158 · Granted Nov 15, 2011

Absorbent wound dressing containing a hydrogel layer

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,058,499
App. No.
10/496,158
Granted
Nov 15, 2011
Kind
B2
Abstract

A wound dressing comprising: a liquid-permeable top sheet having a wound facing surface and a back surface, said top sheet being adapted to block or restrict passage of liquid from the back surface to the wound facing surface; and an insoluble hydrogel layer adjacent to the back surface of the top sheet.

Claims (22)

1. A wound dressing comprising: a liquid-permeable top sheet having a wound facing surface and a back surface, said top sheet having greater permeability to the flow of liquid away from the wound facing surface than to the flow of liquid towards the wound facing surface, thereby blocking or restricting passage of liquid from the back surface to the wound facing surface; a hydrogel layer adjacent to and bonded to the back surface of the top sheet; and an absorbent layer adjacent to the hydrogel layer, on the opposite side of the hydrogel from the back surface of the top sheet; wherein the top sheet is formed from a liquid-impermeable sheet material provided with tapered capillaries, each capillary having a base substantially in the wound facing surface of the top sheet and an apical opening remote from the wound facing surface of the top sheet; wherein the capillaries are substantially in the form of truncated cones; and wherein the hydrogel layer is apertured in register with apertures in the top sheet, wherein said wound dressing maintains a suitably moist wound environment.

2. A wound dressing according to claim 1 , wherein the absorbent layer comprises a layer of hydrophilic foam, a superabsorbent, or a combination thereof.

3. A wound dressing according to claim 1 , wherein the absorbent layer further comprises a medicament.

4. A wound dressing according to claim 1 , wherein the dressing further comprises a substantially liquid-impermeable backing layer over the absorbent layer.

5. A wound dressing according to claim 4 , further comprising a layer of adhesive on the surface of the backing layer facing the top sheet.

6. A wound dressing according to claim 5 , wherein the backing layer extends beyond at least one edge of the absorbent layer to provide an adhesive-coated margin adjacent to said edge for adhering the dressing to a surface.

7. A wound dressing according to claim 1 , wherein the top sheet comprises a porous, substantially hydrophobic, non-woven fabric.

8. A wound dressing according to claim 1 , wherein the capillaries have a base opening dimension from 0.15 mm to 6 mm, and an apical opening dimension of from 0.1 to 2.5 mm.

9. A wound dressing according to claim 8 , wherein the capillaries have a base opening dimension of from 0.5 mm to 1.5 mm, and an apical opening dimension of from 0.1 to 0.5 mm.

10. A wound dressing according to claim 1 , wherein the capillaries have an average angle of taper of from 10 to 60 degrees.

11. A wound dressing according to claim 1 , wherein the hydrogel layer has a dry basis weight from 10 to 200 g/m 2 .

12. A wound dressing according to claim 1 , wherein the hydrogel layer comprises a hydrogel material selected from polyurethane gels, biopolymer gels, carboxymethyl cellulose gels, hydroxyethyl cellulose gels, hydroxypropyl methyl cellulose, modified acrylamides and mixtures thereof.

13. A wound dressing according to claim 1 , wherein the hydrogel layer comprises a hydrogel material selected from gels formed from vinyl alcohols, vinyl esters, vinyl ethers and carboxy vinyl monomers, meth(acrylic) acid, acrylamide, N-vinyl pyrrolidone, acylamidopropane sulphonic acid, plutonic (block polyethylene glycol, block polypropylene glycol)polystyrene maleic acid, NN-dimethylacrylamide, diacetone acrylamide or acryloyl morpholine.

14. A wound dressing according to claim 1 , wherein the hydrogel layer comprises an emollient.

15. A wound dressing according to claim 14 , wherein the emollient is selected from the group consisting of white soft paraffin, yellow soft paraffin, liquid paraffin, urea creams, lanolin, sodium pyrrolidone carboxylate, evening primrose extract (gamma linolenic acid), soya oil, tea tree oil, coconut oil, almond oil, camomile extract, cod liver oil, peanut oil, emu oil, aloe vera, sunflower oil, avocado oil, jojoba oil, cocoamide, and mixtures thereof.

16. A wound dressing according to claim 1 , wherein the hydrogel layer comprises an active therapeutic agent or an antimicrobial agent.

17. A wound dressing according to claim 16 , wherein the hydrogel layer comprises a silver compound.

18. A wound dressing according to claim 1 , further comprising one or more protective cover sheets over the wound facing surface of the top sheet.

19. A wound dressing according to claim 1 , wherein the dressing is sterile and packaged in a microorganism-impermeable container.

20. A method of treating a wound comprising the step of applying a wound dressing comprising a liquid-permeable top sheet having a wound facing surface and a back surface, said to sheet having greater permeability to the flow of liquid away from the wound facing surface than to the flow of liquid towards the wound facing surface, thereby blocking or restricting passage of liquid from the back surface to the wound facing surface; a hydrogel layer adjacent to and bonded to the back surface of the top sheet; and all absorbent layer adjacent to the hydrogel layer, on the opposite side of the hydrogel from the back surface of the top sheet; wherein the top sheet is formed from a liquid-impermeable sheet material provided with tapered capillaries, each capillary having a base substantially in the wound facing surface of the top sheet and an apical opening remote from the wound facing surface of the top sheet; wherein the capillaries are substantially in the form of truncated cones; and wherein the hydrogel layer is apertured in register with apertures in the to sheet, wherein said wound dressing maintains a suitably moist wound environment, to the wound with said top sheet contacting said wound.

21. A wound dressing according to claim 1 , wherein the hydrogel layer has a dry basis weight of form 10 to 100 g/m 2 .

22. A wound dressing according to claim 1 , wherein the hydrogel layer is bonded to the back surface of the top sheet.

Assignments (17)
RELEASE OF SECURITY INTEREST IN PATENTS Recorded Nov 7, 2019
From: WILMINGTON TRUST, NATIONAL ASSOCIATION
To: KCI USA, INC.; KCI LICENSING, INC.
Reel/Frame 050966/0547 →
RELEASE OF SECURITY INTEREST IN PATENTS Recorded Nov 6, 2019
From: WILMINGTON TRUST, NATIONAL ASSOCIATION
To: KINETIC CONCEPTS, INC.; KCI USA, INC.; ACELITY L.P. INC.; CHIRON HOLDINGS, INC.; CHIRON TOPCO, INC.; KCI ANIMAL HEALTH, LLC; KCI HOLDING COMPANY, INC.; KCI HOMECARE, INC.; KCI IMPORTS, INC.; KCI INTERNATIONAL, INC.; KCI LICENSING, INC.; KCI PROPERTIES LIMITED; KCI REAL HOLDINGS, L.L.C.; KCI REAL PROPERTY LIMITED; KCI USA REAL HOLDINGS, L.L.C.; TECHNIMOTION, LLC
Reel/Frame 050945/0278 →
RELEASE OF SECURITY INTEREST Recorded Oct 11, 2019
From: BANK OF AMERICA, N.A.
To: KCI USA, INC.
Reel/Frame 050710/0955 →
RELEASE OF SECURITY INTEREST REEL/FRAME 040098/0268 Recorded Feb 8, 2017
From: WILMINGTON TRUST
To: KCI USA, INC.
Reel/Frame 041666/0320 →
SECURITY AGREEMENT Recorded Feb 7, 2017
From: KCI USA, INC., AS GRANTOR
To: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
Reel/Frame 041650/0013 →
RELEASE OF SECURITY INTEREST IN INTELLECTUAL PROPERTY Recorded Feb 6, 2017
From: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
To: KCI LICENSING, INC., AS GRANTOR; TECHNIMOTION, LLC, A DELAWARE LIMITED LIABILITY COMPANY, AS GRANTOR; SYSTAGENIX WOUND MANAGEMENT (US), INC., A DELAWARE CORPORATION, AS GRANTOR
Reel/Frame 041395/0044 →
LIMITED THIRD LIEN INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Oct 7, 2016
From: KCI USA, INC.; LIFECELL CORPORATION; KCI LICENSING, INC.
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 040291/0237 →
SECOND LIEN SECURITY AGREEMENT Recorded Sep 21, 2016
From: KCI USA, INC.; LIFECELL CORPORATION; KCI LICENSING, INC.
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 040098/0268 →
SECURITY INTEREST Recorded Feb 17, 2016
From: KINETIC CONCEPTS, INC.; KCI USA, INC.; ACELITY L.P. INC.; CHIRON HOLDINGS, INC.; CHIRON TOPCO, INC.; KCI ANIMAL HEALTH, LLC; KCI HOLDING COMPANY, INC.; KCI HOMECARE, INC.; KCI IMPORTS, INC.; KCI INTERNATIONAL, INC.; KCI LICENSING, INC.; KCI PROPERTIES LIMITED; KCI REAL HOLDINGS, L.L.C.; KCI REAL PROPERTY LIMITED; KCI USA REAL HOLDINGS, L.L.C.; LIFECELL CORPORATION; TECHNIMOTION, LLC
To: WILMINGTON TRUST, NATIONAL ASSOCIATION
Reel/Frame 037845/0497 →
MERGER AND CHANGE OF NAME Recorded May 11, 2015
From: SYSTAGENIX WOUND MANAGEMENT (US),INC.; KCI USA, INC.
To: KCI USA, INC.
Reel/Frame 035645/0178 →
MERGER AND CHANGE OF NAME Recorded Feb 11, 2015
From: SYSTAGENIX WOUND MANAGEMENT (US), INC.; KCI USA, INC.
To: KCI USA, INC.
Reel/Frame 034954/0870 →
SECURITY AGREEMENT Recorded Oct 29, 2013
From: SYSTAGENIX WOUND MANAGEMENT (US), INC.
To: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
Reel/Frame 031508/0011 →
RELEASE OF SECURITY INTEREST Recorded Oct 28, 2013
From: J.P. MORGAN EUROPE LIMITED
To: SYSTAGENIX WOUND MANAGEMENT (US), INC.
Reel/Frame 031506/0186 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 21, 2010
From: JOHNSON & JOHNSON MEDICAL LIMITED
To: SYSTAGENIX WOUND MANAGEMENT IP CO. B.V.
Reel/Frame 024563/0265 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 21, 2010
From: ETHICON, INC.; JOHNSON & JOHNSON; JOHNSON & JOHNSON MEDICAL LIMITED; JOHNSON & JOHNSON MEDICAL B.V.; JANSSEN PHARMACEUTICA N.V.; CILAG AG; CILAG HOLDING AG; JEVCO LIMITED
To: SYSTAGENIX WOUND MANAGEMENT (US), INC.; SYSTAGENIX WOUND MANAGEMENT IP CO. B.V.
Reel/Frame 024563/0368 →
SECURITY AGREEMENT Recorded Jan 30, 2009
From: SYSTAGENIX WOUND MANAGEMENT (US), INC.
To: J.P. MORGAN EUROPE LIMITED
Reel/Frame 022177/0037 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 8, 2009
From: JOHNSON & JOHNSON MEDICAL LIMITED
To: SYSTAGENIX WOUND MANAGEMENT (US), INC.
Reel/Frame 022071/0797 →